Brought to you by 
AliveCor gains $10.5mm via its Series B venture round
27 Oct 2014
Executive Summary
Cardiovascular device firm AliveCor Inc. has raised $10.5mm through its Series B venture round. New investor Khosla Ventures and current shareholder Burrill & Co. led and were joined by returning investors Qualcomm Ventures and Oklahoma Life Sciences Fund. The company will use the funds to launch and market its mobile electrocardiogram device once it is cleared by the FDA. Khosla Ventures will contribute one board member.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AliveCor gains $10.5mm via its Series B venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice